Streetbeat News

Analyst Ratings

TME

Citigroup has maintained its Neutral rating for Tencent Music Enter Gr (TME) but lowered its price target from $7.50 to $7.00. TME shares are currently trading up 5.01% over the last 24 hours, at $6.50 per share. A move to $7.00 would account for a 7.69% increase from the current share price.

Portfolio Pulse from Benzinga Insights

August 16, 2023 | 5:00 pm

VLO

Over the past 3 months, 12 analysts have published their opinion on Valero Energy (NYSE:VLO) stock. The company has an average price target of $146.83, a 2.65% decrease from the previous average price target of $150.82. The ratings are determined by predicting the company's future earnings and revenue streams.

Portfolio Pulse from Benzinga Insights

August 16, 2023 | 5:00 pm

SWN

Mizuho has maintained its Neutral rating for Southwestern Energy (NYSE:SWN) but lowered its price target from $9.00 to $8.00. Southwestern Energy's shares are currently trading at $6.43, up 0.62% over the last 24 hours. A move to $8.00 would represent a 24.42% increase from the current share price.

Portfolio Pulse from Benzinga Insights

August 16, 2023 | 5:00 pm

PNR

TD Cowen has maintained its Outperform rating for Pentair (NYSE:PNR) and increased its price target from $65.00 to $75.00. Pentair, a global leader in the water treatment industry, saw its shares trading down 0.28% over the last 24 hours, at $68.84 per share. A move to $75.00 would account for a 8.95% increase from the current share price.

Portfolio Pulse from Benzinga Insights

August 16, 2023 | 5:00 pm

SLND

Southland Holdings' stock has been downgraded from Buy to Neutral by DA Davidson, with a lowered price target from $12 to $7. Craig-Hallum also lowered its price target from $14 to $9.

Portfolio Pulse from Benzinga Newsdesk

August 16, 2023 | 4:59 pm

ALC

Needham analyst David Saxon has reiterated a 'Buy' rating on Alcon (NYSE:ALC) and raised the price target from $94 to $98.

Portfolio Pulse from Benzinga Newsdesk

August 16, 2023 | 4:56 pm

IOVA

Chardan Capital analyst Geulah Livshits has reiterated a 'Buy' rating on Iovance Biotherapeutics (NASDAQ:IOVA) and maintained a price target of $29.

Portfolio Pulse from Benzinga Newsdesk

August 16, 2023 | 4:54 pm

CMRX

HC Wainwright & Co. analyst Edward White has reiterated a 'Buy' rating on Chimerix (NASDAQ:CMRX) and maintained an $11 price target.

Portfolio Pulse from Benzinga Newsdesk

August 16, 2023 | 4:51 pm

SLND

Craig-Hallum analyst Christian Schwab maintains a 'Buy' rating on Southland Holdings (AMEX:SLND) but has lowered the price target from $14 to $9.

Portfolio Pulse from Benzinga Newsdesk

August 16, 2023 | 4:45 pm

GEHC

Wells Fargo has initiated coverage on GE HealthCare Technologies Inc (NASDAQ:GEHC) with an Overweight rating and a price target of $90. The analyst believes GEHC is well-positioned to capitalize on the recent approval of Alzheimer's drugs, which should drive demand for imaging equipment. However, risks include increased competition, slower-than-expected uptake of new product launches, inflationary and supply chain headwinds, a slowdown in procedure volumes, and China volume-based procurement risk.

Portfolio Pulse from Vandana Singh

August 16, 2023 | 4:42 pm